Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
Year: 2019
Type: review
Source: Drug Resistance Updates
Institutions: University of Parma, Amsterdam University Medical Centers, Amsterdam UMC Location Vrije Universiteit Amsterdam, Technion – Israel Institute of Technology, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Ospedale di Parma, University of Pisa
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G3989004436
OpenAlex ID: W2973445191
